VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $116,178,000 | +34.8% | 4,999,064 | -7.7% | 4.34% | +20.7% |
| Q1 2018 | $86,192,000 | -38.5% | 5,414,064 | -20.1% | 3.59% | -39.8% |
| Q4 2017 | $140,228,000 | +13.6% | 6,778,159 | -21.3% | 5.97% | +12.4% |
| Q3 2017 | $123,423,000 | -18.4% | 8,612,913 | -1.5% | 5.31% | -13.5% |
| Q2 2017 | $151,220,000 | +90.3% | 8,741,048 | +21.3% | 6.13% | +75.4% |
| Q1 2017 | $79,479,000 | +12.7% | 7,205,675 | +48.4% | 3.50% | +13.1% |
| Q4 2016 | $70,502,000 | +25.3% | 4,855,500 | +111.9% | 3.09% | +34.2% |
| Q3 2016 | $56,254,000 | +39.2% | 2,291,400 | +14.2% | 2.30% | +27.5% |
| Q2 2016 | $40,407,000 | -2.8% | 2,006,300 | +26.9% | 1.81% | +12.9% |
| Q1 2016 | $41,579,000 | – | 1,580,950 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |